Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
Titel:
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
Auteur:
Ray, Kausik K Oru, Ena Rosenson, Robert S Jones, Jeremiah Ma, Xiaosu Walgren, Jennie Haupt, Axel Verma, Subodh Gaudet, Daniel Nicholls, Stephen J Ruotolo, Giacomo